1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Element Biosciences Acquires Loop Genomics

M&A Deal Summary

Element Biosciences Acquires Loop Genomics

On February 8, 2022, Element Biosciences acquired life science company Loop Genomics

Acquisition Highlights
  • This is Element Biosciences’ 1st transaction in the Life Science sector.
  • This is Element Biosciences’ 1st transaction in the United States.
  • This is Element Biosciences’ 1st transaction in California.

M&A Deal Summary
Date 2022-02-08
Target Loop Genomics
Sector Life Science
Buyer(s) Element Biosciences
Deal Type Add-on Acquisition

Target

Loop Genomics

San Jose, California, United States
Loop Genomics is a synthetic long-read sequencing company developing and commercializing products in a wide variety of genetic analysis applications, including among others, genome, transcriptome, microbiome, and immune repertoire sequencing. Loop Genomics was founded in 2015 and is headquartered in San Jose, California.

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Element Biosciences

San Diego, California, United States
Category Company
Founded 2017
Sector Life Science
DESCRIPTION

Element Biosciences is a multi-disciplinary life science company currently focused on developing disruptive DNA sequencing technology for research and diagnostic markets. Element Biosciences was founded in 2017 and its headquarters is located in San Diego, California.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal